After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Phreesia (NYSE:PHR) and its peers.
Healthcare technology company Phreesia (NYSE:PHR) exceeded Wall Street’s revenue expectations in Q1 CY2025, as sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased from -$0.35 in the same quarter last year.
Healthcare technology company Phreesia (NYSE:PHR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased from -$0.35 in the same quarter last year.
Healthcare technology company Phreesia (NYSE:PHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.5% year on year to $115.9 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.07 per share was 35.6% above analysts’ consensus estimates.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and the rest of the healthcare technology for providers stocks fared in Q4.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and worst performers in the healthcare technology for providers industry.
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers.
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
